Related Experiment Video
Updated: Jul 8, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
ABC multidrug transporters: structure, function and role in chemoresistance
1University of Guelph, Department of Molecular & Cellular Biology, Guelph Ontario, N1G 2W1, Canada. fsharom@uoguelph.ca
Multidrug efflux pumps like P-glycoprotein (ABCB1) contribute to cancer chemoresistance. Genetic variations in these ATP-binding cassette (ABC) transporters may influence drug response, but their clinical impact is still debated.
Area of Science:
- Molecular Biology and Pharmacology
- Cancer Biology and Therapeutics
- Genetics and Personalized Medicine
Background:
- Three ATP-binding cassette (ABC)-superfamily multidrug efflux pumps, P-glycoprotein (ABCB1), MRP1 (ABCC1), and ABCG2 (BCRP), are critical for cellular defense against xenobiotics.
- These transporters are implicated in chemoresistance in human tumors, limiting the efficacy of cancer chemotherapy.
- The interaction of drugs with these efflux pumps involves hydrophobic and H-bonding interactions within their substrate-binding pockets.
Purpose of the Study:
- To review the role of ABC-superfamily multidrug efflux pumps in chemoresistance and normal physiology.
- To discuss the challenges and controversies surrounding the clinical application of efflux pump modulators in cancer treatment.
- To explore the potential impact of single nucleotide polymorphisms (SNPs) in ABC drug-efflux pumps on drug response and disease susceptibility.
Main Methods:
- Literature review and synthesis of existing research on ABC transporters, chemoresistance, and pharmacogenetics.
- Analysis of the functional interactions between drugs and efflux pump proteins.
- Discussion of genetic variations (genotypes and haplotypes) and their potential effects on transporter expression and function.
Main Results:
- ABC transporters are crucial for protecting tissues but also mediate drug resistance in tumors.
- Clinical trials using efflux pump modulators have yielded disappointing results.
- The precise role of genetic polymorphisms in ABC transporters regarding drug response and disease susceptibility remains unclear and controversial.
Conclusions:
- While ABC efflux pumps are vital for normal physiology and contribute to cancer chemoresistance, their modulation for therapeutic benefit has faced significant hurdles.
- Further research is needed to elucidate the complex effects of genetic variations in these transporters on clinical outcomes.
- The clinical significance of ABC transporter genotypes and haplotypes in cancer therapy and disease susceptibility requires further investigation and validation.
More Related Videos
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
ABC Transporters: Exporter
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...